Resonance Health attended the EASL Digital NAFLD Summit 2021 on 16 - 17 September and participated with insights into developments in artificial intelligence-based approaches to NAFLD management using HepaFat-AI.

We are delighted to present the abstract we shared titled "Diagnostic accuracy of liver steatosis using artificial intelligence".

To read it please click here.

Attachments

  • Original document
  • Permalink

Disclaimer

Resonance Health Limited published this content on 24 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 September 2021 03:41:06 UTC.